Travere Therapeutics to Report Third Quarter 2024 Financial Results

TVTX 10.21.2024

Full Press ReleaseSEC FilingsOur TVTX Tweets

About Gravity Analytica

Recent News

  • 01.14.2025 - 43rd Annual J.P. Morgan Healthcare Conference
  • 01.13.2025 - Travere Therapeutics Provides Corporate Update and 2025 Outlook
  • 01.10.2025 - Prakhar Agrawal

Recent Filings

  • 01.22.2025 - 144 Report of proposed sale of securities
  • 01.13.2025 - 8-K Current report
  • 01.13.2025 - EX-99.1 EX-99.1
PDF Version

SAN DIEGO,Oct. 21, 2024(GLOBE NEWSWIRE) --Travere Therapeutics, Inc.(NASDAQ: TVTX) today announced it will report third quarter 2024 financial results onThursday, October 31, 2024, before the open of theU.S.financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at8:30 a.m. ET.

The webcast and dial-in information can be accessed on the Investor page of Travere’s website atir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website.

AboutTravere Therapeutics

AtTravere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visittravere.com.

Contact Info

Media:888-969-7879mediarelations@travere.comInvestors:888-969-7879IR@travere.com

Primary Logo

Source: Travere Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com